RECENT NEWS

The 2026 edition of the Biomedical Science Industry Handbook is available to read online now.

ALZpath – which develops diagnostic tools for Alzheimer's disease and related dementias – has announced a licensing agreement with Siemens Healthineers for use of its proprietary pTau217 antibody in the development of a pTau217 assay.

BD (Becton, Dickinson and Company) has announced the expansion of its respiratory and sexually transmitted infection (STI) diagnostics offerings in Europe following IVDR certification of two VIASURE assays developed by Certest Biotec for use on the BD MAX System.

A multinational workshop for strengthening disease surveillance in Africa has revealed the persistent antibiotic resistance of cholera-causing bacteria on the continent.

The National Institute for Health and Care Excellence (NICE) has announced Professor Jonathan Benger CBE as incoming Chief Executive, taking over from Dr Samantha Roberts.

Roche has secured CE Mark approval for its mass spectrometry reagent pack for antibiotics drug monitoring. This establishes Roche's in-vitro diagnostics (IVD) menu as the broadest available for any automated mass spectrometry platform, including already 39 of the most frequently tested targets.

A revolutionary quantum sensing project that could transform cancer treatment by tracking how immune cells interact with tumours has been awarded a prestigious £2 million Future Leaders Fellowship.

A new blood test can accurately identify different types of breast cancer – meaning patients can be matched to the correct treatment without the need for a biopsy.

Patients in the UK and Singapore could gain faster access to cutting-edge healthcare innovations under a new partnership bringing two globally respected regulators together with one of the world’s leading biotech creators.

Digital pathology firm PathAI has announced a new partnership with University Medical Center Utrecht, one of Europe’s leading academic medical centres, to deploy AISight Dx, PathAI’s digital pathology image management system, to accelerate the adoption of AI algorithms.

A human challenge trial supported by the National Institute for Health and Care Research (NIHR)has shown that a new vaccine could offer better protection against whooping cough.

The UK Health Security Agency (UKHSA) has identified a new recombinant mpox virus in England in an individual who had recently travelled to Asia.

South Korean molecular diagnostics firm Seegene has announced the establishment of a new subsidiary in France to reinforce its European presence and support global sales expansion.

Roche has announced it has received the CE Mark for its cobas BV/CV (Bacterial Vaginosis/Candida Vaginitis) assay to accurately identify specific bacteria and yeast responsible for BV and CV in vaginal samples from symptomatic patients collected using the cobas PCR Media proprietary tube.

A newly published study has identified 'confounders' interfering with cancer signals, key physiological factors that can interfere with cancer-associated cell-free DNA (cfDNA), offering a foundation for improving the accuracy of liquid biopsy tests.

Randox has announce that its pioneering genetic test for type 1 diabetes (T1D) risk has received CE marking, the first regulatory approval of its kind anywhere in the world. The test, developed by Randox in collaboration with the University of Exeter, received regulatory UK Conformity Assessed (UKCA) approval in early 2024.

Lab Thread, a UK-based life science software company, has announced the beta launch of its flagship unified laboratory software platform.

Magentus, a provider of healthcare technology across the UK and Australia, has announced the acquisition of Labflow, a modern, cloud-native suite of pathology software products.

Roche’s first point-of-care test for the diagnosis of whooping cough (pertussis) and other Bordetella infections, has been granted US Food and Drug Administration (FDA) 510(k) clearance and Clinical Laboratory Improvement Amendments of 1988 (CLIA) waiver, in addition to CE IVDR certification.

The British In Vitro Diagnostic Association (BIVDA) has announced the appointment of David Thorne as BIVDA’s Head of NHS Policy.